• June 3-6, 2024
  • San Diego Convention Center, California


George Lin

George Lin, JD

EVP & Chief Strategy Officer
Hua Medicine
Mr. George Lin, J.D., a healthcare veteran brings with over 18 years of investment banking and legal experience working with numerous private and public companies globally. Prior to joining Hua Medicine in 2018, he was APAC Head of Consumer, Retail and Healthcare Investment Banking and Head of Hong Kong and Taiwan Investment Banking for Bank of America Merrill Lynch. Mr. Lin has led M&A transactions valued (in aggregate) in excess of US$20 billion and raised financings valued (in aggregate) at over US$40 billion. Since April 2018, Mr. Lin has served as a member of the Biotech Advisory Panel of the Hong Kong Stock Exchange. Prior to Bank of America Merrill Lynch, Mr. Lin also worked at Credit Suisse as an investment banker in their Hong Kong, San Francisco and Los Angeles offices, and at O'Melveny & Myers LLP as a corporate attorney in their Los Angeles Office. Mr. Lin received a Bachelor of Sciences degree in Biological Sciences from the University of California at Davis and a Juris Doctor degree from The University of Chicago Law School.
Speaking In
  • 03-Jun-2024
    Hua Medicine
    Company Presentation Theater 2


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.